Expert Interview
A Second Opinion: Discussing the recent data from Takeda's phase 2b trial of TAK-861 as a treatment for patients with narcolepsy.
Ticker(s): TAK, JAZZInsititution: Duke
- Professor of Neurology at Duke University.
- Currently manages hundreds of OSA patients and is able to discuss the MARIPOSA Phase II clinical trial results.
- Main focus is in epilepsy, sleep disorders, and clinical neurophysiology interpretation.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
